首页 | 本学科首页   官方微博 | 高级检索  
检索        

HGF/c-MET信号通路抑制剂在抗胰腺癌中的研究进展
引用本文:乔银标,杨波.HGF/c-MET信号通路抑制剂在抗胰腺癌中的研究进展[J].国际肿瘤学杂志,2017,44(4).
作者姓名:乔银标  杨波
作者单位:苏州大学附属第三医院肝胆外科, 常州,213003
摘    要:胰腺癌是恶性程度较高的肿瘤之一.靶向治疗日渐成为胰腺癌治疗的重要组成部分.研究证实肝细胞生长因子及其受体(HGF/c-MET)信号通路在胰腺癌发生、发展过程中起重要作用,通过抑制该条信号通路能够起到显著的抗胰腺癌作用.因此,HGF/c-MET靶向抑制剂的研究为胰腺癌的治疗开辟了一条新的途径.

关 键 词:肝细胞生长因子  胰腺肿瘤  原癌基因蛋白质c-met

Research progress of HGF/c-MET signaling pathway inhibitors in anti-pancreatic cancer
Qiao Yin-biao,Yang Bo.Research progress of HGF/c-MET signaling pathway inhibitors in anti-pancreatic cancer[J].Journal of International Oncology,2017,44(4).
Authors:Qiao Yin-biao  Yang Bo
Abstract:Pancreatic cancer is one of the most malignant tumors.Targeted therapy has become an important part of the treatment of pancreatic cancer.The signaling pathways such as hepatocyte growth factor/c-MET (HGF/c-MET) signaling pathway, inhibition of which may exerts an antitumor effect, play extremely important roles in the occurrence and development of pancreatic cancer.Therefore, the research of HGF/c-MET targeted inhibitors opens up a new avenue for treatment of pancreatic cancer.
Keywords:Hepatocyte growth factor  Pancreatic neoplasms  Proto-oncogene proteins c-met
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号